1-6 of 6
Therese B. Bevers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study

Soley Bayraktar, Sema Baghaki, Jimin Wu, Diane D. Liu, Angelica M. Gutierrez-Barrera, Therese B. Bevers, Vicente Valero, Nour Sneige, Banu K. Arun
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2020) 13 (9): 795–802.
https://doi.org/10.1158/1940-6207.CAPR-20-0095
Published: 02 September 2020
View articletitled, Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study
Open the PDF for Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study in another window
Journal Articles

NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project-1 Results: Decision Making in Breast Cancer Risk Reduction

Christine Holmberg, Hanna Bandos, Angela Fagerlin, Therese B. Bevers, Tracy A. Battaglia, D. Lawrence Wickerham, Worta J. McCaskill-Stevens
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2017) 10 (11): 625–634.
https://doi.org/10.1158/1940-6207.CAPR-17-0076
Published: 31 October 2017
View articletitled, NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project-1 Results: Decision Making in Breast Cancer Risk Reduction
Open the PDF for NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project-1 Results: Decision Making in Breast Cancer Risk Reduction in another window
Includes: Supplementary data
Journal Articles

Abstract PR-08: The willingness to accept chemoprevention strategies by women at increased risk of breast cancer

Mfon S. Cyrus-David, Therese B. Bevers, Weiwei Wang, Karen Basen-Engquist
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): PR-08.
https://doi.org/10.1158/1940-6207.PREV-10-PR-08
Published: 24 October 2014
View articletitled, Abstract PR-08: The willingness to accept chemoprevention strategies by women at increased risk of breast cancer
Journal Articles

Abstract B65: Biomarker effects of an oral green tea extract, Polyphenon E, in women with a history of hormone receptor-negative breast cancer

Katherine D. Crew, Kimberly A. Ho, Powel Brown, Heather Greenlee, Therese B. Bevers, Banu Arun, Clifford Hudis, Heather L. McArthur, Jenny Chang, Mothaffar Rimawi, Lana Vornik, Terri L. Cornelison, James Cardelli, Regina M. Santella, Antai Wang, Scott M. Lippman, Dawn L. Hershman
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2012) 5 (11_Supplement): B65.
https://doi.org/10.1158/1940-6207.PREV-12-B65
Published: 23 January 2014
View articletitled, Abstract B65: Biomarker effects of an oral green tea extract, Polyphenon E, in women with a history of hormone receptor-negative breast cancer
Journal Articles

Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer

Katherine D. Crew, Powel Brown, Heather Greenlee, Therese B. Bevers, Banu Arun, Clifford Hudis, Heather L. McArthur, Jenny Chang, Mothaffar Rimawi, Lana Vornik, Terri L. Cornelison, Antai Wang, Hanina Hibshoosh, Aqeel Ahmed, Mary Beth Terry, Regina M. Santella, Scott M. Lippman, Dawn L. Hershman
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2012) 5 (9): 1144–1154.
https://doi.org/10.1158/1940-6207.CAPR-12-0117
Published: 04 September 2012
View articletitled, Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer
Open the PDF for Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Walter M. Cronin, Reena S. Cecchini, James N. Atkins, Therese B. Bevers, Louis Fehrenbacher, Eduardo R. Pajon, James L. Wade, III, André Robidoux, Richard G. Margolese, Joan James, Carolyn D. Runowicz, Patricia A. Ganz, Steven E. Reis, Worta McCaskill-Stevens, Leslie G. Ford, V. Craig Jordan, Norman Wolmark, for the National Surgical Adjuvant Breast and Bowel Project
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (6): 696–706.
https://doi.org/10.1158/1940-6207.CAPR-10-0076
Published: 02 June 2010
View articletitled, Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer
Open the PDF for Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer in another window
Includes: Supplementary data